How Should a Clinic Evaluate an RPM Vendor for Security Before Signing a Contract?

What an RPM Vendor Security Review Actually Tests

An RPM vendor security review is the process of deciding whether a remote patient monitoring company can be trusted with clinical data, connected devices, patient communications, and access to a care network. It is not simply a questionnaire about whether the vendor has “HIPAA compliance” or uses encryption. The practical question is whether the vendor can demonstrate, with evidence, that its people, systems, software, suppliers, and incident-response processes protect health information throughout the service relationship. For getpulse.care readers, the review should cover both technical controls and operational promises: Who can see patient data? How quickly would an incident be reported? What happens if the vendor stops operating? Can exported records be recovered?

Also worth reading: How Should Clinics Evaluate a Healthcare Software Vendor? · How Should a Clinic Build and Evaluate a Care Pilot Using a Practical Evaluation Framework? · What Security Questions Should Buyers Ask an RPM Vendor in 2026?

The review becomes more important because RPM commonly combines several technologies, including patient-reported surveys, vital-sign devices, cellular or internet connections, cloud platforms, messaging tools, and interfaces with an electronic health record. A weakness in any component can expose the entire workflow, even if the core monitoring platform itself is well built. A useful review therefore tests the whole chain from the home to the clinician, not just a polished security page. It should also distinguish between a stated policy, a current configuration, and independent evidence. “We encrypt data” is a policy claim; documented encryption settings, key-management procedures, logs, and test results are stronger evidence.

As of the September 29, 2026 evaluation date, a clinic should expect security review to include current software bills of materials, vulnerability-management practices, access-control reports, business-associate agreements, penetration-test summaries, disaster-recovery evidence, and data-deletion procedures. Exact thresholds vary by organization, but several basic numbers should be defined before procurement. The contract should identify an initial breach-notification deadline, contract-renewal dates, annual assurance periods, and the number of records or patients that the vendor can support without changing its control environment. The output of the review should be a documented decision: approved, approved with tracked conditions, or rejected.

Why Software Supply Chain and Remote Devices Need Extra Scrutiny

RPM expands a clinic’s attack surface because information may pass through devices and services outside the clinic’s direct control. A blood-pressure cuff may transmit measurements through a vendor gateway, a mobile application, cloud infrastructure, and an EHR integration before a care team sees the result. Each handoff can introduce an account, an API credential, a software update, or a service provider. Security review should map those paths and identify which party owns each control. If a vendor relies on a subcontractor for device software, cloud hosting, text messaging, analytics, or support, the primary vendor should still explain how that supplier is assessed and what happens when it fails.

The 2024 XZ Utils incident is a useful general lesson, although it was not an RPM event. CISA and the open-source security community disclosed an advanced backdoor affecting certain XZ Utils releases and the packages built with them; the issue emerged through investigative reporting and ecosystem-wide analysis in March 2024. The event showed how a seemingly small software component can affect many downstream products and operating environments. The relevant RPM question is not whether a product uses an RPM package, an App Store package, or a standard Linux package. It is whether the vendor can identify its direct and transitive software dependencies, monitor them for defects, and respond quickly when a widely used dependency is compromised.

That lesson should be translated into procurement language. A clinic can ask for a software bill of materials for the production service, a policy for responding to critical upstream vulnerabilities, and examples of how the vendor has handled a security advisory in the prior 12 months. A useful escalation threshold may be any actively exploited vulnerability, any vulnerability exposing regulated data, or any unsupported dependency receiving a critical vendor warning. Plain-language answers are important: the vendor should explain whether it can disable an affected integration within 24 hours, notify customers within 24 to 72 hours, and provide a tested mitigation or replacement plan. Evidence of dependable operations matters more than a claim that a vendor uses a “secure software development lifecycle.”

What Technical Evidence Should a Clinic Request?

A credible review begins with an architecture and data-flow description. The vendor should identify what data it collects, why each category is needed, where it is stored, how long it is retained, and which organizations process it. The clinic should request the latest penetration-test executive summary or relevant testing letter, vulnerability-management metrics, access-control policy, encryption description, and disaster-recovery test summary. A complete report is useful, but a high-level summary can be appropriate if it includes test dates, scope, severity findings, remediation status, and limitations. The clinic should not accept “SOC 2 certified” as a precise term; it should identify the actual service, framework, period, and report type, such as a SOC 2 Type II report where applicable.

Technical controls should be evaluated in context. Encryption in transit and at rest is a reasonable baseline, but encryption does not correct weak passwords, excessive permissions, or unsafe exports. The vendor should explain its supported authentication methods, phishing-resistant options for privileged users, session limits, password policy, and remote-support controls. A practical benchmark is to prohibit production administrative access through shared accounts and to require named, individually attributable accounts. The review should also ask whether multifactor authentication is required for workforce accounts, contractors, administrators, and access to systems containing identifiable health information. The clinic should verify whether a claimed feature is enabled by default rather than merely available.

Connected-device controls deserve equal attention. The vendor should state whether devices use unique identities, whether firmware is signed, whether updates can be delayed during unsafe conditions, and whether the device can be securely retired. It should explain what happens when a device is lost, stolen, returned, or permanently offline. A security review can also request metrics for patch age, unresolved high-severity findings, privileged-access reviews, employee departures, and backup restoration tests. The review should use objective thresholds, such as no unresolved critical production vulnerabilities, documented remediation plans for high-severity items, and a named owner and due date for every accepted exception.

## How to Evaluate Contracts, Privacy, and Business Continuity

The security review does not end with technical testing. Contract terms determine whether the vendor’s promises are enforceable and usable during an incident. A clinic should obtain a business-associate agreement where required, a data-processing addendum, information-security exhibit, and service-level schedule. The documents should define permitted uses of patient data, subcontractor approval, minimum security standards, audit rights, cooperation with legal requests, breach notification, return or deletion of data, and assistance with data portability. The contract should also state which services and products the security terms cover, because a separate analytics product or support portal may not be included in a standard assurance report.

Timing is particularly important. Ask the vendor to commit to notifying the clinic without undue delay and within a specific period after confirming a security incident that affects the clinic’s data. A 24-hour target may be reasonable for a serious or suspected breach, while 48 to 72 hours may be the outer operational limit when facts are incomplete. Legal obligations can require notification to regulators or affected individuals, so the contract should say that the vendor will not delay notice to complete its investigation. It should also require updates at agreed intervals, preservation of evidence, root-cause analysis, remediation milestones, and a final incident report. A notification clause without a content standard offers limited practical value.

Exit planning is another frequently missed part of the review. Ask how the clinic can retrieve patient data, device records, documents, and integrations in a documented format, and how long the vendor will support migration. A reasonable target is a complete export within 30 days of a written request for a routine transition, with urgent incident exports handled sooner. The contract should specify whether the vendor will cooperate with a new provider, what assistance is included, and how deletion will be verified after the retention period. The clinic should also identify a “break-glass” path for disabling integrations and revoking credentials if the relationship deteriorates. These provisions can be more important than a minor difference between two vendors’ monthly prices.

Comparing Managed RPM, Custom Tools, and Hybrid Models

Clinic buyers usually compare a mature RPM vendor with a build-your-own system, a general patient-engagement platform, or a hybrid arrangement. These choices are not interchangeable. A managed RPM service may provide faster implementation, device logistics, clinical dashboards, and support, but it may also introduce vendor concentration, subscription dependence, and limited control over data export. A custom system can provide more control over workflows and integrations, but it transfers responsibility for security, maintenance, monitoring, backups, and vendor coordination to the clinic. A general communication platform may handle outreach and engagement well while requiring a separate device and monitoring workflow.

The comparison should be based on total operating burden rather than the license line alone. Hospitals and health systems should include implementation labor, integration work, device replacement, clinical training, support staffing, cybersecurity monitoring, downtime procedures, and future upgrades. A lower recurring price can become more expensive if the platform needs a dedicated interface engineer or creates substantial manual review for missed escalations. The table below is a conceptual comparison, not a product ranking or substitute for a formal security review.

For getpulse.care, the relevant distinction is operational: a care network needs a vendor whose security controls match its ability to supervise and exit the service. A smaller clinic may gain more consistency from a managed provider, while a large integrated health system may need contractual audit rights, dedicated tenancy, and custom data-delivery requirements. No model is inherently secure. The better option is the one with verified controls, clear accountability, realistic staffing, and a sustainable cost.

Common Mistakes That Produce False Confidence

The most common mistake is treating HIPAA compliance language as a complete security verdict. HIPAA compliance is an organization-wide legal and operational responsibility, not a certification that proves every technical control works. A vendor may be able to sign a business-associate agreement, use encryption, and pass an audit, yet still have weaknesses in supply-chain management, device retirement, support access, or incident communications. Buyers should separate the legal requirement from the evidence for reliability, confidentiality, integrity, availability, and safe clinical use.

Another mistake is accepting vendor questionnaires without testing scope. A questionnaire answer may be true for a corporate environment but false for the product used by the clinic. Reviewers should verify product names, hosting regions, workforce locations, remote-support tools, subcontractors, and data categories. They should also compare the vendor’s security page with the actual contract and service configuration. Stale evidence is another problem: a report from three years ago may not describe the current platform. The clinic should ask what changed since the report, whether there were acquisitions or migrations, and whether the current product is in scope.

Buyers also make the mistake of asking for “all security documentation” without defining a review process. Excessive information can bury important findings, while a narrow request can leave major risks unknown. Start with the architecture, data map, assurance reports, recent testing, vulnerability metrics, incident history, and contractual commitments. Escalate deeper requests only where the risk justifies them. The review should record each unanswered question, the vendor’s response, evidence received, residual risk, responsible owner, and review date. This converts a subjective conversation into a decision that can be repeated during renewal or after a material change.

Finally, clinics sometimes compare vendors on feature count instead of fit. A platform with more dashboards, messages, or integrations may create more clinical and security complexity than the care network can manage. A smaller platform may be better if it clearly identifies thresholds, routes alerts, supports escalation, and produces reliable reports. Security review should ask whether the tool is designed for the organization’s patient volume, staffing model, language needs, clinical pathways, and downtime procedures. A feature that increases alert volume without improving follow-through can be a liability.

When Should a Clinic Act, and What Should It Do First?

A clinic should begin the review before signing a contract, but it should not wait for a major incident to identify urgent weaknesses. The first action is to classify the decision by risk. A pilot involving 25 patients and limited data may justify a proportionate review, while a deployment across 2,500 patients, multiple clinics, and sensitive data deserves deeper testing. As a general rule, an organization should complete an initial review before any production patient data enters the environment and before granting vendor personnel access to internal systems. Renewal review should begin at least 90 days before the notice deadline when the contract permits a non-renewal decision.

The first 30 days can focus on documentation and architecture. Request the security package, data-flow diagram, business-associate agreement, information-security addendum, current assurance report, penetration-test summary, incident-response summary, disaster-recovery results, and device-security overview. Confirm that the named product is the product being purchased. Establish a cross-functional group with clinical operations, privacy or compliance, information security, procurement, finance, and the EHR or integration owner. A clinical team can identify unsafe alert paths; technical staff can assess access and integration; procurement can translate findings into contract requirements.

Within 60 days, test the evidence and convert unresolved issues into written conditions. Review the vendor’s access model, support process, vulnerability remediation, data export, subcontractor list, and notification commitments. If the vendor will not provide certain reports, ask for equivalent evidence and record the limitation. For a higher-risk deployment, consider a focused technical assessment of the integration, tenant configuration, or device-management process. A pilot should include simulated missed transmissions, role changes, device loss, account revocation, export testing, and a downtime exercise.

By 90 days, the decision should be documented with explicit residual risks. Stop or defer a launch if the vendor cannot identify where patient data is stored, cannot revoke access, refuses required contractual protections, or has an unresolved critical issue without a credible mitigation. A conditional approval may be reasonable when the remaining risk is limited, temporary, and controlled by the clinic. The final record should state when the issue will be revisited, who owns remediation, and what evidence will close it. For care networks, the same standard should apply across each clinic, because a weak local configuration can undermine a secure central platform.

What Cost and Pricing Information Should Buyers Expect?

RPM pricing is rarely just one number. Managed vendors may quote a monthly or annual subscription per patient, per device, per clinic, or per tier of service. Device costs may be separate or bundled, and implementation, integration, training, cellular service, replacement equipment, and premium support can add material expense. Because actual prices vary widely and vendors often negotiate privately, buyers should compare the full three-year cost rather than a headline rate. A useful worksheet should include setup, platform fees, devices, connectivity, interface development, clinical staffing, cybersecurity review, renewal increases, termination fees, and data-export assistance.

Security itself may not appear as a separate line item. It may be included in enterprise pricing, charged as an assessment, or supplied through contractual commitments rather than a product. A clinic should not assume that a lower price means weaker security, or that a higher price proves stronger security. The relevant question is whether the fee supports the controls the organization needs and whether the vendor can provide evidence for them. If a contract requires an annual audit or penetration test, confirm whether it covers the clinic’s exact environment and whether the clinic may review the resulting summary.

Small clinics may prefer a managed offering because it shifts some device and infrastructure work to the vendor, but they should budget for internal ownership of patient consent, escalation, account provisioning, and incident coordination. Large care networks may obtain volume discounts but face higher integration and migration costs. A practical financial threshold is to compare the vendor’s total annual cost with the cost of the staff time required to operate an alternative, including coverage when a device fails or an alert is missed. The cheapest option is not the one with the smallest invoice; it is the one whose total cost and risk remain acceptable across the intended service period.

As of September 29, 2026, buyers should also ask about price changes, minimum patient commitments, overage charges, device replacement terms, and the cost of withdrawing from the service. The contract should state how unused capacity and early termination will be handled. Transparent commercial terms reduce the chance that a security advantage is offset by an unplanned exit cost. Pricing should therefore be evaluated alongside privacy, availability, clinical workflow, and the vendor’s ability to support the next phase of the care network.

The Review Decision and a Practical Approval Standard

The definitive answer is that an RPM vendor security review should be treated as a documented due-diligence and contracting process, not a one-time sales presentation. A clinic should approve a vendor only when it can identify the data and systems in scope, verify meaningful safeguards, understand the supply chain, assign responsibility, and secure enforceable incident, continuity, audit, and exit terms. The strongest evidence usually combines technical artifacts, operating metrics, current independent assurance, and a willingness to answer difficult questions. A questionnaire alone cannot show whether controls work in production.

For a practical approval standard, require a current architecture and data map; named accounts and appropriate authentication; encryption and tested backup controls; device identity and update procedures; vulnerability-management and software-dependency visibility; a current testing or assurance package; a tested incident-response plan; precise notification terms; and a workable export and deletion process. Define exceptions in writing, assign owners, and set dates. Revisit the decision at renewal and whenever the vendor changes hosting, device technology, ownership, major subcontractors, or the type of data processed.

This approach is not intended to make innovation impossible. It is intended to make adoption safer for patients and sustainable for the care team. RPM can support earlier outreach, more consistent measurement, and better coordination, but only if alerts, data, devices, and human responsibilities work together. A security-conscious clinic does not ask whether every technology is perfect; it asks whether risks are known, controls are proportionate, and the organization can respond when something goes wrong. That is the defensible standard for evaluating an RPM partner in 2026.